Prezista Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents
Condition:   Healthy Interventions:   Drug: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide FDC;   Drug: Darunavir;   Drug: Emtricitabine/Tenofovir Alafenamide;   Drug: Cobicistat Sponsor:   Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials